ORPHA:519930
Fungal keratitis
Also known as: Keratomycosis · Mycotic keratitis
Publications
5,557
Trials
13
Interventional, condition-specific
Researchers
1,007
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare disorder of the anterior segment of the eye characterized by ocular infection by human-pathogenic fungi, most commonly Aspergillus, Candida, or Fusarium species, which gain access into the corneal stroma through a defect in the corneal epithelium. Risk factors include trauma, ocular surface disease, contact lenses, or immunocompromised state. Patients present with pain, foreign body sensation, redness, photophobia, tearing, secretion, or blurred vision. The condition may be complicated by corneal destruction and perforation, endophthalmitis, scleritis, and panophthalmitis.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0033821
- UMLS:C1262117
- NCIT:C128370
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
5,557 matched papers (3,413 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPresent
13 matched on ClinicalTrials.gov (2 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
5,557
5,557 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
5,557 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
3,413 in the last 10 years · low confidence
Phrase hits: 5,557 · MeSH hits: 0
Who's working on it?
1,007
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Lin J13 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, NO.16 Jiangsu Road, Qingdao, Shandong Province, 266003, China. Electronic address: linjing_yk@126.com.
Papers in Europe PMC - 02Zhang L13 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province, China.
Papers in Europe PMC - 03Wang Q12 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, NO.16 Jiangsu Road, Qingdao, Shandong Province, 266003, China. Electronic address: yankewangqian@126.com.
Papers in Europe PMC - 04Zhao G12 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, NO.16 Jiangsu Road, Qingdao, Shandong Province, 266003, China. Electronic address: zhaoguiqiu_good@126.com.
Papers in Europe PMC - 05Li C11 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, NO.16 Jiangsu Road, Qingdao, Shandong Province, 266003, China. Electronic address: yankelicui@126.com.
Papers in Europe PMC - 06Das S8 papers · 2026
Cornea and Anterior Segment, Shantilal Shanghvi Cornea Institute, L V Prasad Eye Institute, Bhubaneswar, Odisha, India.
Papers in Europe PMC - 07Li Y8 papers · 2026
School of Pharmacy, Lanzhou University, Lanzhou, 730000, China.
Papers in Europe PMC - 08Wang Z8 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province, 266003, China.
Papers in Europe PMC - 09Sharma S7 papers · 2026
Department of Quality Assurance, ISF College of Pharmacy, Moga, 142001, Punjab, India.
Papers in Europe PMC - 10Chi M6 papers · 2026
Department of Ophthalmology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province, 266003, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
13
interventional trials for this specific condition
13 interventional trials matched this specific condition name; 2 currently recruiting in our sample. 100 trials are registered for keratitis, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
13 interventional trials — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 92.8th percentile).
low confidence · 92.8th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
13 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06658002·RECRUITING·Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
Conditions: Fungal Keratitis · Corneal Ulcer·Matched via name phrase
- NCT06463678·NOT YET RECRUITING·Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis
Conditions: Fungal Keratitis·Matched via name phrase
Broader category: keratitis
100
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06975748·RECRUITING·A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis
Conditions: Neurotrophic Keratitis·Matched via name phrase
- NCT07308938·NOT YET RECRUITING·Fluorometholone Study
Conditions: Keratitis Bacterial · Corneal Ulcer (Diagnosis)·Matched via name phrase
- NCT07329686·RECRUITING·Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
Conditions: Herpes Simplex Keratitis · Corneal Neovascularization·Matched via name phrase
- NCT06964269·RECRUITING·Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease
Conditions: Autoimmune Diseases · Dry Eye · Neurotrophic Keratitis·Matched via name phrase
- NCT07568730·RECRUITING·A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic Keratitis
Conditions: Neurotrophic Keratitis·Matched via name phrase
- NCT06451172·RECRUITING·Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
Conditions: Bacterial Keratitis · Antibiotic-resistant Bacteria · Infections, Bacterial · Corneal Diseases·Matched via name phrase
- NCT07452588·NOT YET RECRUITING·Effect of Sodium Chloride 5% Solution as an Adjuvant Treatment With Antimicrobial Therapy in the Treatment of Bacterial Infectious Keratitis
Conditions: Infectious Keratitis · Adjuvant Treatment Bacterial Infectious Keratitis · Sodium Chloride 5% Solution·Matched via name phrase
- NCT06999733·RECRUITING·A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
Conditions: Neurotrophic Keratitis·Matched via name phrase
- NCT07073729·NOT YET RECRUITING·Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study
Conditions: Neurotrophic Keratitis·Matched via name phrase
- NCT05927428·RECRUITING·Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis
Conditions: Neurotrophic Keratitis·Matched via name phrase
- NCT06474442·RECRUITING·A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis
Conditions: Herpes Simplex Virus Type I Stromal Keratitis·Matched via name phrase
- NCT07394257·RECRUITING·Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis
Conditions: Bacterial Keratitis · Recalcitrant Infectious Keratitis · Corneal Ulcer·Matched via name phrase
- NCT06213649·RECRUITING·Parasitic Ulcer Treatment Trial
Conditions: Acanthamoeba Keratitis·Matched via name phrase
- NCT03918408·RECRUITING·Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking
Conditions: Keratoconus, Unstable · Bacterial Keratitis · Ectasia of Cornea·Matched via name phrase
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Fungal keratitis" OR "Keratomycosis" OR "Mycotic keratitis"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Fungal keratitis" OR "Keratomycosis" OR "Mycotic keratitis"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 13 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"keratitis"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (5557) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T18:01:12.104Z
